Paper10951
Combined alpha- and beta-adrenoreceptors blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise.
Koch G. Br J Clin Pharmacol, 1976. Cited by 47 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Combined alpha- and beta-adrenoreceptors blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise. Papers, record 10951. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10951
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Combined alpha- and beta-adrenoreceptors blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic alpha-Antagonists | Major topic |
| Adrenergic beta-Antagonists | Major topic |
| Hemodynamics | Major topic |
| Hypertension | Major topic |
| Physical Exertion | Major topic |
| Administration, Oral | |
| Adult | |
| Blood Pressure | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Labetalol | |
| Male | |
| Middle Aged | |
| Pulse | |
| Renin |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,428,793 | Comparison of the effects of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7428793 | PubMed |
| 7,093,100 | Blood pressure response to labetalol in twice and three times daily administration during a 24-hour period. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7093100 | PubMed |
| 7,082,539 | Rapid reduction of blood pressure with acute oral labetalol. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7082539 | PubMed |
| 6,310,204 | Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension. | Klin Wochenschr | 1983 | https://conductscience.org/library/papers/6310204 | PubMed |
| 6,124,265 | Comparison of labetalol with other anti-hypertensive drugs. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6124265 | PubMed |
| 583,322 | Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/583322 | PubMed |
| 526,408 | Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/526408 | PubMed |
| 526,397 | Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/526397 | PubMed |
| 385,023 | A comparison of the effects of labetalol, bendrofluazide and their combination in hypertension. | Br J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/385023 | PubMed |
| 106,867 | Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combined alpha- and beta-adrenoreceptor blockade by labetalol. | Br Heart J | 1979 | https://conductscience.org/library/papers/106867 | PubMed |
| 26,446 | Biochemical evidence for the dual action of labetalol on alpha- and beta-adrenoceptors. | Br J Pharmacol | 1978 | https://conductscience.org/library/papers/26446 | PubMed |
| 25,757 | Labetalol: a review of its pharmacology and therapeutic use in hypertension. | Drugs | 1978 | https://conductscience.org/library/papers/25757 | PubMed |
| 25,186 | Intrinsic sympathomimetic activity of beta-adrenoceptor blocking agents. | Eur J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/25186 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| REN | 5,972 | PubTator's text mining | https://conductscience.org/library/genes/5972 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10951
GET https://conductscience.org/api/papers/v1/10951/authors